Condition
Pulmonary Disease, Chronic Obstructive
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 857 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)NCT07780656 · 2026-09-11
RECRUITINGA Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)NCT07780669 · 2026-08-27
RECRUITINGA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)NCT07759245 · 2026-08-07
RECRUITINGeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 InflammationNCT07177339 · 2025-10-20
RECRUITINGDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)NCT06961214 · 2025-06-23
RECRUITINGDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 InflammationNCT06959095 · 2025-06-20
RECRUITINGInvestigation of Walking Training With Different Slope Types in COPD PatientsNCT06283004 · 2025-04-09
RECRUITINGThe Effect of Gait Training Using Different Slope Types on Balance in COPD PatientsNCT06644898 · 2025-04-09
RECRUITINGBenefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)NCT06755008 · 2025-02-19
RECRUITINGThe ROAM Research Study Therapy (LTOT) VersionNCT06810323 · 2025-01-14
RECRUITINGTrial to Determine Effective Aspirin Dose in COPDNCT05265299 · 2023-05-16
RECRUITINGMonitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD ExacerbationsNCT05704881 · 2023-03-03
RECRUITINGReducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at HomeNCT05730088 · 2023-02-15
RECRUITINGTargeted Nutrient Supplement in COPD (NUTRECOVER-trial)NCT03807310 · 2020-02-19
RECRUITINGThe London COPD Exacerbation CohortNCT02755974 · 2009-01-01
RECRUITINGA Study of the Effect of a Nurse Navigator Program on High Risk PatientsNCT05592847 · 2027-01-01
NOT_YET_RECRUITINGFamily-centred Pulmonary Rehabilitation to Empower CarersNCT07791147 · 2026-09-01
NOT_YET_RECRUITINGVirtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPDNCT07714252 · 2026-08-06
ENROLLING_BY_INVITATIONGenerative AI for Medication Counselling and Adherence in Community PharmaciesNCT07649577 · 2026-01-01
COMPLETEDA Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation PowderNCT07252908 · 2025-12-22
COMPLETEDChronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third WaveNCT06890208 · 2025-06-11
COMPLETEDEarly Screening of Young COPD and Pre-COPDNCT06844175 · 2025-03-01
NOT_YET_RECRUITINGDigital Implementation of the German S3 Clinical Practice Guideline for MultimorbidityNCT06831994 · 2025-02-26
ACTIVE_NOT_RECRUITINGDetecting Systemic Carbon Dioxide Levels With a Novel BiosensorNCT06367686 · 2025-01-30
COMPLETEDA Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06527144 · 2024-09-14
COMPLETEDEXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)NCT07103642 · 2024-08-15
COMPLETEDExtracorporeal CO2 Removal for Acute Decompensation of COPDNCT04582799 · 2024-08-01
WITHDRAWNDetermination of Factors Effecting Falls in Patients With COPDNCT06483776 · 2024-07-01
UNKNOWNChanges in Dyspnea, Activity and Sleep in COPD by Video-Based Breathing ExercisesNCT06477367 · 2024-06-20
COMPLETEDEXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (MITOS: EROS+CP US Study)NCT06742736 · 2024-05-31
COMPLETEDChronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, 2nd WaveNCT06407154 · 2024-05-21
COMPLETEDUM CRMC RecuR Score PilotNCT05765903 · 2024-03-31
WITHDRAWNPEP Buddy Impact on Breathing, Exercise, and Sleep Quality in COPD PatientsNCT06290245 · 2024-03-23
COMPLETEDDetermination of Body Awareness and the Functional Movement in Patients With COPDNCT06298994 · 2024-03-08
UNKNOWNA Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients Who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)NCT06744374 · 2024-02-29
COMPLETEDCoronary Computed Tomography Angiography In Rheumatoid Arthritis StudyNCT07363980 · 2024-02-21
ENROLLING_BY_INVITATIONImpact of COPD on Sexual Health, Loneliness, and Well-beingNCT06240078 · 2024-02-20
COMPLETEDTask-specific Training for Patients With Acute Exacerbation of COPDNCT06224075 · 2024-01-15
UNKNOWNEvaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06099652 · 2023-12-08
COMPLETEDA Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary DiseaseNCT06154837 · 2023-11-27
ACTIVE_NOT_RECRUITINGRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionNCT06149494 · 2023-11-20
COMPLETEDExercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory DiseaseNCT06124859 · 2023-11-01
UNKNOWNDevelopment and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPDNCT06063733 · 2023-10-30
UNKNOWNDigital Tool Enhancing GPs' Information Management for Patients with Multimorbidity - a Pilot StudyNCT06061172 · 2023-10-02
COMPLETEDDiagnosing Obstructive Lung Disease With Point of Care UltrasoundNCT06251271 · 2023-08-01
COMPLETEDChronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational StudyNCT05961163 · 2023-07-24
TERMINATEDTOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study ProtocolNCT04088942 · 2023-07-01
WITHDRAWNA Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT04923347 · 2023-06-06
COMPLETEDPragmatic Trial to Enhance Quality Safety, and Patient Experience in COPDNCT05718102 · 2023-05-15
ACTIVE_NOT_RECRUITINGPrediction of COPD Severity Using Electrical Impedance TomographyNCT06359145 · 2023-04-01
UNKNOWNDeep Learning Diagnostic and Risk-stratification for IPF and COPDNCT05318599 · 2023-04-01
UNKNOWNRespiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.NCT05863091 · 2023-03-09
UNKNOWNTreatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil LevelsNCT05059873 · 2023-03-05
TERMINATEDNeuromuscular Fatigue During Exercise in COPD-HF OverlapNCT05235685 · 2023-02-21
UNKNOWNPhase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT05677347 · 2023-01-23
COMPLETEDAir Filtration for COPD in VA Population of VeteransNCT05913765 · 2023-01-11
ACTIVE_NOT_RECRUITINGThe Effect of Aromatherapy Massage on Pain, Anxiety and ComfortNCT06295874 · 2023-01-05
UNKNOWNA Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters and Patient-reported Outcomes for Monitoring Disease Activity in Patients With COPDNCT05655832 · 2022-12-05
COMPLETEDInvolvement of Skeletal Muscle Fibrocytes in sarcOpenia in Patients With Chronic ObstRuctive Pulmonary DiseaseNCT04939454 · 2022-11-29
COMPLETEDTo Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPDNCT05535972 · 2022-10-14
COMPLETEDCommon interventions
PlaceboDRUG138TiotropiumDRUG65SalmeterolDRUG22Tiotropium BromideDRUG20OlodaterolDRUG19PlaceboOTHER12GSK573719DRUG9RespimatDEVICE9Albuterol/salbutamolDRUG8Tiotropium + OlodaterolDRUG8ELLIPTADEVICE7FF/UMEC/VIDRUG7HandihalerDEVICE7Fluticasone propionateDRUG6Tiotropium 18 mcgDRUG6fluticasone furoate/vilanterolDRUG5No interventionOTHER5Olodaterol (BI 1744)DRUG5Pulmonary rehabilitationOTHER5Usual CareOTHER5VilanterolDRUG5Aclidinium BromideDRUG4BEA 2180 BRDRUG4Budesonide/FormoterolDRUG4DiskusDEVICE4
Leading sponsors
Boehringer Ingelheim
222
GlaxoSmithKline
210
AstraZeneca
15
Pfizer
13
Henan University of Traditional Chinese Medicine
9
University of Minnesota
7
Maastricht University Medical Center
6
Universitätsklinikum Hamburg-Eppendorf
6
Washington University School of Medicine
6
Bayer
5
Radboud University Medical Center
5
University of Michigan
5
University of Washington
5
US Department of Veterans Affairs
5
VA Office of Research and Development
5
Trial status mix
COMPLETED683
UNKNOWN77
TERMINATED48
WITHDRAWN19
RECRUITING15
ACTIVE_NOT_RECRUITING9
ENROLLING_BY_INVITATION3
NOT_YET_RECRUITING3
Phase mix
NA187
PHASE3169
PHASE2124
PHASE4104
PHASE150
EARLY_PHASE13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.